Global Parkinson's Disease Drug Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Parkinson's Disease Drug Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Parkinson's Disease Drug Market Overview:
Global Parkinson's Disease Drug Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Parkinson's Disease Drug involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Parkinson's Disease Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Parkinson's Disease Drug market in 2020.
Global Parkinson's Disease Drug Market Segmentation
By Type, Parkinson's Disease Drug market has been segmented into:
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Others
By Application, Parkinson's Disease Drug market has been segmented into:
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Parkinson's Disease Drug market are:
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals
1. Market Overview of Parkinson's Disease Drug
1.1 Parkinson's Disease Drug Market Overview
1.1.1 Parkinson's Disease Drug Product Scope
1.1.2 Market Status and Outlook
1.2 Parkinson's Disease Drug Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Parkinson's Disease Drug Historic Market Size by Regions (2015-2020)
1.4 Parkinson's Disease Drug Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Parkinson's Disease Drug Sales Market by Type (2015-2026)
2.1 Global Parkinson's Disease Drug Historic Market Size by Type (2015-2020)
2.2 Global Parkinson's Disease Drug Forecasted Market Size by Type (2021-2026)
2.3 Sinemet-CR
2.4 Trastal
2.5 Madopar
2.6 COMT Inhibitor
2.7 Others
3. Covid-19 Impact Parkinson's Disease Drug Sales Market by Application (2015-2026)
3.1 Global Parkinson's Disease Drug Historic Market Size by Application (2015-2020)
3.2 Global Parkinson's Disease Drug Forecasted Market Size by Application (2021-2026)
3.3 Under 40 Years Old
3.4 40-65 Years Old
3.5 Above 65 Years Old
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Parkinson's Disease Drug Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Parkinson's Disease Drug Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Parkinson's Disease Drug Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Parkinson's Disease Drug Business
5.1 Merck
5.1.1 Merck Company Profile
5.1.2 Merck Parkinson's Disease Drug Product Specification
5.1.3 Merck Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Akorn
5.2.1 Akorn Company Profile
5.2.2 Akorn Parkinson's Disease Drug Product Specification
5.2.3 Akorn Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 GSK
5.3.1 GSK Company Profile
5.3.2 GSK Parkinson's Disease Drug Product Specification
5.3.3 GSK Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Novartis
5.4.1 Novartis Company Profile
5.4.2 Novartis Parkinson's Disease Drug Product Specification
5.4.3 Novartis Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Boehringer Ingelheim
5.5.1 Boehringer Ingelheim Company Profile
5.5.2 Boehringer Ingelheim Parkinson's Disease Drug Product Specification
5.5.3 Boehringer Ingelheim Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Teva Pharmaceutical
5.6.1 Teva Pharmaceutical Company Profile
5.6.2 Teva Pharmaceutical Parkinson's Disease Drug Product Specification
5.6.3 Teva Pharmaceutical Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Abbvie
5.7.1 Abbvie Company Profile
5.7.2 Abbvie Parkinson's Disease Drug Product Specification
5.7.3 Abbvie Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Kyowa Hakko Kirin Pharma
5.8.1 Kyowa Hakko Kirin Pharma Company Profile
5.8.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product Specification
5.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Astellas Pharma
5.9.1 Astellas Pharma Company Profile
5.9.2 Astellas Pharma Parkinson's Disease Drug Product Specification
5.9.3 Astellas Pharma Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Desitin Arzneimittel
5.10.1 Desitin Arzneimittel Company Profile
5.10.2 Desitin Arzneimittel Parkinson's Disease Drug Product Specification
5.10.3 Desitin Arzneimittel Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Endo Pharmaceuticals
5.11.1 Endo Pharmaceuticals Company Profile
5.11.2 Endo Pharmaceuticals Parkinson's Disease Drug Product Specification
5.11.3 Endo Pharmaceuticals Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 F.Hoffmann-La Roche
5.12.1 F.Hoffmann-La Roche Company Profile
5.12.2 F.Hoffmann-La Roche Parkinson's Disease Drug Product Specification
5.12.3 F.Hoffmann-La Roche Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 H.Lundbeck
5.13.1 H.Lundbeck Company Profile
5.13.2 H.Lundbeck Parkinson's Disease Drug Product Specification
5.13.3 H.Lundbeck Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Valeant
5.14.1 Valeant Company Profile
5.14.2 Valeant Parkinson's Disease Drug Product Specification
5.14.3 Valeant Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Apokyn
5.15.1 Apokyn Company Profile
5.15.2 Apokyn Parkinson's Disease Drug Product Specification
5.15.3 Apokyn Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Orion
5.16.1 Orion Company Profile
5.16.2 Orion Parkinson's Disease Drug Product Specification
5.16.3 Orion Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Stada Arzneimittel
5.17.1 Stada Arzneimittel Company Profile
5.17.2 Stada Arzneimittel Parkinson's Disease Drug Product Specification
5.17.3 Stada Arzneimittel Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 US WorldMeds
5.18.1 US WorldMeds Company Profile
5.18.2 US WorldMeds Parkinson's Disease Drug Product Specification
5.18.3 US WorldMeds Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Valeant Pharmaceuticals
5.19.1 Valeant Pharmaceuticals Company Profile
5.19.2 Valeant Pharmaceuticals Parkinson's Disease Drug Product Specification
5.19.3 Valeant Pharmaceuticals Parkinson's Disease Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Parkinson's Disease Drug Market Size (2015-2026)
6.2 North America Parkinson's Disease Drug Key Players in North America (2015-2020)
6.3 North America Parkinson's Disease Drug Market Size by Type (2015-2020)
6.4 North America Parkinson's Disease Drug Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Parkinson's Disease Drug Market Size (2015-2026)
7.2 East Asia Parkinson's Disease Drug Key Players in North America (2015-2020)
7.3 East Asia Parkinson's Disease Drug Market Size by Type (2015-2020)
7.4 East Asia Parkinson's Disease Drug Market Size by Application (2015-2020)
8. Europe
8.1 Europe Parkinson's Disease Drug Market Size (2015-2026)
8.2 Europe Parkinson's Disease Drug Key Players in North America (2015-2020)
8.3 Europe Parkinson's Disease Drug Market Size by Type (2015-2020)
8.4 Europe Parkinson's Disease Drug Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Parkinson's Disease Drug Market Size (2015-2026)
9.2 South Asia Parkinson's Disease Drug Key Players in North America (2015-2020)
9.3 South Asia Parkinson's Disease Drug Market Size by Type (2015-2020)
9.4 South Asia Parkinson's Disease Drug Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Parkinson's Disease Drug Market Size (2015-2026)
10.2 Southeast Asia Parkinson's Disease Drug Key Players in North America (2015-2020)
10.3 Southeast Asia Parkinson's Disease Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Parkinson's Disease Drug Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Parkinson's Disease Drug Market Size (2015-2026)
11.2 Middle East Parkinson's Disease Drug Key Players in North America (2015-2020)
11.3 Middle East Parkinson's Disease Drug Market Size by Type (2015-2020)
11.4 Middle East Parkinson's Disease Drug Market Size by Application (2015-2020)
12. Africa
12.1 Africa Parkinson's Disease Drug Market Size (2015-2026)
12.2 Africa Parkinson's Disease Drug Key Players in North America (2015-2020)
12.3 Africa Parkinson's Disease Drug Market Size by Type (2015-2020)
12.4 Africa Parkinson's Disease Drug Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Parkinson's Disease Drug Market Size (2015-2026)
13.2 Oceania Parkinson's Disease Drug Key Players in North America (2015-2020)
13.3 Oceania Parkinson's Disease Drug Market Size by Type (2015-2020)
13.4 Oceania Parkinson's Disease Drug Market Size by Application (2015-2020)
14. South America
14.1 South America Parkinson's Disease Drug Market Size (2015-2026)
14.2 South America Parkinson's Disease Drug Key Players in North America (2015-2020)
14.3 South America Parkinson's Disease Drug Market Size by Type (2015-2020)
14.4 South America Parkinson's Disease Drug Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Parkinson's Disease Drug Market Size (2015-2026)
15.2 Rest of the World Parkinson's Disease Drug Key Players in North America (2015-2020)
15.3 Rest of the World Parkinson's Disease Drug Market Size by Type (2015-2020)
15.4 Rest of the World Parkinson's Disease Drug Market Size by Application (2015-2020)
16 Parkinson's Disease Drug Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Parkinson s Disease Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|